Clinical trial for Alzheimer Dementia
Official title Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
ClinicalTrials.gov ID: NCT07222280
What this study is testing
- What it's testing
- The study wants to see if the Quest AD‑Detect blood test can identify Alzheimer’s disease earlier than usual and tell it apart from other causes of confusion in hospitalized patients.
- Who it's for
- Hospitalized adults who are being evaluated for delirium, confusion, or other cognitive problems.
- What's involved
- Participants will have the Quest AD‑Detect blood test taken while in the hospital. After discharge, they will have follow‑up visits over the next six months to review their risk and health status.
- Time commitment
- The study lasts about six months after the hospital stay, with follow‑up visits during that period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 90
You may be able to join if
- Ages 60 to 90 years old
- No prior diagnosis of dementia
- Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc.
You likely can't join if
- Age under 60 years
- Prior diagnosis of dementing illness or other organic etiology to cognitive impairment
The study team makes the final eligibility decision.
Where it is enrolling
- Crossville, Tennessee, United States
- Harriman, Tennessee, United States
- Knoxville, Tennessee, United States
- Lenoir City, Tennessee, United States
- Oak Ridge, Tennessee, United States
- Sevierville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Crossville, Tennessee, United States; Harriman, Tennessee, United States; Knoxville, Tennessee, United States; Lenoir City, Tennessee, United States; Oak Ridge, Tennessee, United States; Sevierville, Tennessee, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.